Cargando…

Prognosis Determinants after Cardioverter-Defibrillators Implantation in Brazil

Detalles Bibliográficos
Autores principales:	Migowski, Arn, Xavier, Regina Maria de Aquino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389881/ https://www.ncbi.nlm.nih.gov/pubmed/28443965 http://dx.doi.org/10.5935/abc.20170034

Ejemplares similares

Seven years of use of implantable cardioverter-defibrillator therapies: a nationwide population-based assessment of their effectiveness in real clinical settings
por: Migowski, Arn, et al.
Publicado: (2015)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022)

Watchful Waiting in an Unusual Cause of Hypoxemia after Implantable Cardioverter-Defibrillator Lead Extraction
por: Bejko, Jonida, et al.
Publicado: (2019)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Obsessive-Compulsive Disorder as a Risk Factor in Patients with Implantable Cardioverter Defibrillator
por: Banihashemian, K, et al.
Publicado: (2011)

Fracture of DF-4 implantable cardioverter defibrillator lead in a pediatric patient
por: Dagriri, Khalid, et al.
Publicado: (2015)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

To the Editor— Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock
por: Winter, Joachim, et al.
Publicado: (2019)

Reply to Yalta and Yetkin—Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Duffett, Stephen A., et al.
Publicado: (2022)

Impact of implantable cardioverter defibrillator on survival in patients with non‐ischemic dilated cardiomyopathy
por: Kataoka, Naoya, et al.
Publicado: (2023)

Think twice before implanting leads in a swimmer: challenges in lead implantation of an implantable cardioverter-defibrillator
por: Varvarousis, Dimitrios, et al.
Publicado: (2021)

Letter to the Editor: Inappropriate subcutaneous implantable cardioverter‐defibrillator discharge related to myopotential oversensing
por: Chery, Godefroy, et al.
Publicado: (2020)

Reply to the Editor— Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock
por: Do, Khuyen, et al.
Publicado: (2019)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
por: de Groot, Joris R.
Publicado: (2023)

Prognosis after Implantation of Cardioverter-Defibrillators in Korean Patients with Brugada Syndrome
por: Son, Myoung Kyun, et al.
Publicado: (2014)

Implantable cardioverter defibrillator therapy for secondary prevention in spontaneous coronary artery dissection: to place or not to place? This is the matter
por: Scagliola, Riccardo, et al.
Publicado: (2020)

An unusual complication during reimplantation of implantable cardioverter defibrillator (ICD) after ICD leads extraction: Distal migration of anchoring sleeve
por: Korkmaz, Ahmet, et al.
Publicado: (2018)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea
por: Uhm, Jae-Sun, et al.
Publicado: (2017)

Primary prevention implantable cardioverter–defibrillator therapy: a matter not yet adequately explored waiting for guidelines update
por: Guaricci, Andrea I., et al.
Publicado: (2017)

The internal jugular vein as an alternative venous access for a revision of a fractured implantable cardioverter-defibrillator lead
por: Pae, Jong Yop, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Factors That Cause Concerns after Cardioverter Defibrillator Implantation
por: Karczewska, Olimpia, et al.
Publicado: (2021)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?
por: Baalman, S. W. E., et al.
Publicado: (2018)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_91pqm509vm1dsrh8meqdb9h3v1